Emerging technologies and quality assurance: The United Kingdom National External Quality Assessment Scheme perspective

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 3, 2007, Pages 243-249

  Jennings, Ian ^a,b   Kitchen, Dianne P ^a   Woods, Timothy A L ^a   Kitchen, Steven ^a   Walker, Isobel D ^a  

^a Rutledge Mews   (United Kingdom)

^b UK NEQAS for Blood Coagulation   (United Kingdom)

Author keywords

D dimer; External quality assessment; Hemophilia; Point of care testing

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; D DIMER; HEPARIN; LUPUS ANTICOAGULANT; RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBIN INHIBITOR;

ANTICOAGULANT THERAPY; BLOOD CLOTTING TEST; HEMOSTASIS; HUMAN; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; UNITED KINGDOM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CALIBRATION; CHEMISTRY, CLINICAL; DRUG MONITORING; FACTOR VIII; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GREAT BRITAIN; HEMATOLOGIC TESTS; HEMOSTASIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; QUALITY CONTROL; THROMBELASTOGRAPHY; VENOUS THROMBOSIS;

EID: 34147218347     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-971810     Document Type: Review

References (28)

1. Jennings I, Greaves M, Mackie IJ, Kitchen S, Woods TA, Preston FE. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002;119:364-369
2. Jennings I, Kitchen S, Woods TA, Preston FE. Multi-laboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost 2005;31:66-72
3. Kitchen S, Jennings I, Woods TA, Kitchen DP, Walker ID, Preston FE. Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 2006;32:492-498
4. Favaloro EJ, Bonar R, Kershaw G, et al. Reducing errors in identification of von Willebrand disease: the experience of the Royal College of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2006;32:505-513
5. Johnson PR. The contribution of proficiency testing to improving laboratory performance and ensuring quality patient care. Clin Leadersh Manag Rev 2004;18:335-341
6. Fitzmaurice DA, Gardiner C, Kitchen S, Mackie I, Murray ET, Machin SJ. British Society of Haematology Taskforce for Haemostasis and Thrombosis. An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 2005;131:156-165
7. Medical Devices Agency. Device Bulletin MDA DB2002(03) March 2002. London: Medical Devices Agency of UK Department of Health; 2002
8. Kitchen S, Kitchen DP, Jennings I, Woods TAL, Walker ID, Preston FE. Point of Care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of 3 different monitors. Thromb Haemost 2006;96:590-596
9. Murray ET, Kitchen DP, Kitchen S, et al. Patient self-management of oral anticoagulation and external quality assessment procedures. Br J Haematol 2003;122:825-828
10. Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 2001;97:685-691
11. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703
13. Lutz CT, Foster PA, Noll WW, et al. Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes. Clin Chem 1998;44:1356-1358
14. Preston FE, Kitchen S, Jennings I, Woods TAA. UK National External Quality Assessment scheme (UK NEQAS) for molecular genetic testing for the diagnosis of familial thrombophilia. Thromb Haemost 1999;82:1556-1557
15. Tripodi A, Peyvandi F, Chantarangkul V, Menegatti M, Mannucci PM. Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations - a cause for concern. Thromb Haemost 2002;88:690-691
16. Hertzberg M, Neville S, Favaloro EJ, MacDonald D. External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005;123:189-193
17. Gray E, Hawkins JR, Morrison M, et al. Establishment of the 1st International Genetic Reference Panel for Factor V Leiden, human gDNA. Thromb Haemost 2006;96(2):215-219
18. Jennings I, Kitchen S, Woods TAL, Preston FE, Greaves M. Clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK NEQAS for Blood Coagulation. Thromb Haemost 1997;77:934-937
19. Arnout J, Meijer P, Vermylen J. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human B2-glycoprotein 1. Thromb Haemost 1999;81:929-934
20. Jennings I, Mackie I, Arnout J, Preston FE. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies; performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004;2:2178-2184
21. Tripodi A, Biasiolo A, Chantarangkul V, Pengo V. Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem 2003;49:1608-1614
22. Gardiner C, Pennaneac'h C, Walford C, Machin SJ, Mackie IJ. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Haematol 2005;128:842-848
23. Stevens SM, Gregory Elliott C, Woller SC, et al. The use of a fixed high sensitivity to evaluate five D-dimer assays' ability to rule out deep venous thrombosis: a novel approach. Br J Haematol 2005;131:341-347
24. Goodacre S, Sampson FC, Sutton AJ, Mason S, Morris F. Variation in the diagnostic performance of D-dimer for suspected deep vein thrombosis. QJM 2005;98:513-527
25. Dempfle CE. D-dimer: standardization versus harmonization. Thromb Haemost 2006;95:399-400
26. Jennings I, Kitchen S, Kitchen DP, Woods TAL, Walker ID. Laboratory D-dimer measurement in the exclusion of DVT: any nearer agreement? Br J Haematol 2006;133(Supp 1):47
27. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006;20:548-553
28. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90